SURGISENSE CORPORATION

Basic Information

5272 River Road
Suite 200
Bethesda, MD, -

http://www.surgisense.com

Company Profile

n/a

Additional Details

Field Value
DUNS: 783945384
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 4


  1. Oxygen Mapping System for Enhanced Colonoscopic Neoplasm Detection

    Amount: $1,072,220.00

    DESCRIPTION provided by applicant Ninety five percent of colorectal cancer develops by a well understood series of genetic mutations over a year time frame beginning as a tissue growth commo ...

    SBIR Phase II 2015 Department of Health and Human Services National Institutes of Health
  2. Device to Improve Treatment of Colorectal CA using O2 Dependent Phosphorescence

    Amount: $1,750,986.00

    DESCRIPTION (provided by applicant): Standard of care for surgical resection of rectal cancer is the performance of low anterior resection (LAR). After removal of the cancerous segment, a surgical sta ...

    SBIR Phase II 2012 Department of Health and Human Services
  3. Device to Improve Treatment of Colorectal Cancer Using O2 Dependent Phosphorescen

    Amount: $228,501.00

    DESCRIPTION (provided by applicant): Anastomotic failure is one of the most feared complications of gastrointestinal surgery due to the resultant morbidity and mortality. Failure of an anastomosis, or ...

    SBIR Phase I 2010 Department of Health and Human Services
  4. A Device to Reduce Anastomotic Failure in the Treatment of Colorectal Cancer

    Amount: $199,385.00

    DESCRIPTION (provided by applicant): Anastomotic failure is one of the most feared complications of gastrointestinal surgery due to the resultant morbidity and mortality. Failure of an anastomosis, or ...

    SBIR Phase I 2009 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government